StoxNarayana Hrudayalaya vs Sai Life Sciences: share price & financials comparison
NSE: NH vs SAILIFE · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Narayana Hrudayalaya vs Sai Life Sciences at a glance
Narayana Hrudayalaya (NH) has a market capitalisation of ₹38,890 Cr, against ₹37,919 Cr for Sai Life Sciences (SAILIFE). Over the past year Sai Life Sciences has returned +94.7%, compared with +5.7% for Narayana Hrudayalaya. On valuation, Narayana Hrudayalaya trades at a lower P/E of 45.3 versus 187.2. Narayana Hrudayalaya earns a higher return on equity (17.2% vs 7.5%). Narayana Hrudayalaya comes out ahead on size, valuation and growth. Sai Life Sciences comes out ahead on profitability, financial health, momentum and technicals. Across the scored metrics below, Narayana Hrudayalaya leads on 5 and Sai Life Sciences on 7. On StoxGud's 10-point checklist, Narayana Hrudayalaya scores 7/10 and Sai Life Sciences scores 6/10.
| Metric | Narayana Hrudayalaya | Sai Life Sciences |
|---|---|---|
| Size | ||
| Market cap | ₹38,890 Cr | ₹37,919 Cr |
| Revenue (latest FY) | ₹7,896 Cr | ₹2,192 Cr |
| Net profit (latest FY) | ₹806 Cr | ₹349 Cr |
| Valuation | ||
| P/E | 45.3 | 187.2 |
| P/B | 7.77 | 14.11 |
| Dividend yield | 0.23% | — |
| Profitability | ||
| Return on equity | 17.2% | 7.5% |
| Net profit margin | 8.4% | 8.5% |
| Operating margin | 18.5% | 29.5% |
| Growth | ||
| Revenue growth (YoY) | +73.0% | +22.5% |
| Net profit growth (YoY) | +16.5% | — |
| Revenue CAGR (multi-year) | +25.0% | — |
| Financial health | ||
| Debt to equity | 0.99 | 0.17 |
| Momentum | ||
| 1-month return | +10.4% | +14.3% |
| 1-year return | +5.7% | +94.7% |
| 3-year CAGR | +22.4% | — |
| 5-year CAGR | +28.5% | — |
| 10-year CAGR | +18.7% | — |
| Distance from 52W high | -8.5% | +0.0% |
| Technicals | ||
| RSI (14) | 71 | 93 |
| Price vs 200-day avg | +3.6% | +47.1% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Narayana Hrudayalaya | Sai Life Sciences |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✓ | ✗ |
| Score | 7/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Narayana Hrudayalaya or Sai Life Sciences?
Narayana Hrudayalaya has a market cap of ₹38,890 Cr and Sai Life Sciences has a market cap of ₹37,919 Cr as of 06 Nov 2026.
Which has a lower P/E, Narayana Hrudayalaya or Sai Life Sciences?
Narayana Hrudayalaya has the lower P/E: Narayana Hrudayalaya trades at 45.3 and Sai Life Sciences at 187.2.
Which gave better returns in the last year, Narayana Hrudayalaya or Sai Life Sciences?
Sai Life Sciences did better: Narayana Hrudayalaya returned +5.7% and Sai Life Sciences returned +94.7% over one year.
Is Narayana Hrudayalaya or Sai Life Sciences a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Narayana Hrudayalaya scores 7/10 and Sai Life Sciences scores 6/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.